XML 42 R29.htm IDEA: XBRL DOCUMENT v3.19.2
Collaboration and Other Agreements - Roche (Details)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Jan. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
performance_obligation
Jun. 30, 2019
USD ($)
Jun. 30, 2018
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2018
USD ($)
Dec. 31, 2018
USD ($)
Collaboration And Other Agreements [Line Items]              
Revenues     $ 10,593 $ 18,834 $ 20,255 $ 23,529  
Deferred revenue, current     14,449   14,449   $ 21,721
Deferred revenue, net of current portion     15,413   15,413   19,001
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc.              
Collaboration And Other Agreements [Line Items]              
Non-refundable upfront payment $ 10,000            
Potential milestone payments and royalties on future sales under agreement   $ 370,000          
Number of performance obligations | performance_obligation   1          
Collaborative agreement transaction price   $ 10,000          
Upfront payment recognition period   30 months          
Deferred revenue             6,000
Deferred revenue, current     4,000   $ 4,000   4,000
Deferred revenue, net of current portion             $ 2,000
Revenues From License Agreements | F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc.              
Collaboration And Other Agreements [Line Items]              
Revenues     $ 1,000 $ 1,000